Cargando…

Expanding Hepatitis C Virus Care and Cure: National Experience Using a Clinical Pharmacist–Driven Model

BACKGROUND: The US National Viral Hepatitis Action Plan depends on additional providers to expand hepatitis C virus (HCV) treatment capacity in order to achieve elimination goals. Clinical pharmacists manage treatment and medication within interdisciplinary teams. The study’s objective was to determ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koren, David E, Zuckerman, Autumn, Teply, Robyn, Nabulsi, Nadia A, Lee, Todd A, Martin, Michelle T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667715/ https://www.ncbi.nlm.nih.gov/pubmed/31363775 http://dx.doi.org/10.1093/ofid/ofz316

Ejemplares similares

Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy
por: Nabulsi, Nadia A., et al.
Publicado: (2020)

Impact of Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Interventions on Persons With Human Immunodeficiency Virus
por: Brizzi, Marisa B, et al.
Publicado: (2020)

Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada
por: Marathe, Gayatri, et al.
Publicado: (2022)

Identification of 19 Novel Hepatitis C Virus Subtypes—Further Expanding HCV Classification
por: Hedskog, Charlotte, et al.
Publicado: (2019)

Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study
por: Pericot-Valverde, Irene, et al.
Publicado: (2023)

Expanding Antiviral Prophylaxis During Pregnancy to Prevent Perinatal Hepatitis B Virus Infection: A Cost-effectiveness Study
por: Du, Jiangyang, et al.
Publicado: (2020)

Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers With Low Surface Antigen Levels
por: Zeng, Qing-Lei, et al.
Publicado: (2020)

High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis With 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH Study
por: Flower, Barnaby, et al.
Publicado: (2021)

Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus
por: Fisher, Dennis G., et al.
Publicado: (2015)

Crushing and Splitting Direct-Acting Antivirals for Hepatitis C Virus Treatment: A Case Series and Literature Review
por: Whelchel, Kristen, et al.
Publicado: (2021)

Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
por: Paltiel, A. David, et al.
Publicado: (2017)

Acceptability and Feasibility of a Pharmacist-Led Human Immunodeficiency Virus Pre-Exposure Prophylaxis Program in the Midwestern United States
por: Havens, Joshua P, et al.
Publicado: (2019)

The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
por: Chew, Kara W., et al.
Publicado: (2014)

The Expanding Role of the Pharmacist in the Management of Hepatitis C Infection
por: Spooner, Linda M.
Publicado: (2011)

Viral Interference Between Dengue Virus and Hepatitis C Virus Infections
por: Liang, Po-Cheng, et al.
Publicado: (2020)

Hepatitis C Within a Single Health System: Progression Along the Cascade to Cure Is Higher for Those With Substance Misuse When Linked to a Clinic With Embedded Support Services
por: Sherbuk, J E, et al.
Publicado: (2018)

Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics
por: Berenguer, Juan, et al.
Publicado: (2016)

Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design
por: Lau, Jillian S Y, et al.
Publicado: (2022)

Shedding of Hepatitis C Virus in Semen of Human Immunodeficiency Virus-Infected Men
por: Turner, Samuel S., et al.
Publicado: (2016)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

Delays in Hepatitis B Immunization Series Completion in People With Human Immunodeficiency Virus
por: Sheikh, Daanish, et al.
Publicado: (2023)

Perspectives of Physician and Pharmacist Stewards on Successful Antibiotic Stewardship Program Implementation: A Qualitative Study
por: Barlam, Tamar F, et al.
Publicado: (2020)

Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion
por: Chu, Carissa E., et al.
Publicado: (2016)

Opportunities to Increase Access to HIV Prevention: Evaluating the Implementation of Pharmacist-Initiated Pre-exposure Prophylaxis in California
por: Hunter, Lauren A, et al.
Publicado: (2023)

Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients
por: Lo Re, Vincent, et al.
Publicado: (2015)

Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study
por: Gowda, Charitha, et al.
Publicado: (2018)

Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program
por: Stone, Mars, et al.
Publicado: (2021)

T-Cell Exhaustion in HIV-1/Hepatitis C Virus Coinfection Is Reduced After Successful Treatment of Chronic Hepatitis C
por: Caraballo Cortés, Kamila, et al.
Publicado: (2023)

Impact of specialty pharmacist integration on time to medication access for pimavanserin
por: Livezey, Sabrina, et al.
Publicado: (2019)

The Relationship Between Hepatitis C Virus Rates and Office-Based Buprenorphine Access in Ohio
por: Brook, Daniel L, et al.
Publicado: (2021)

Disinfection of Syringes Contaminated With Hepatitis C Virus by Rinsing With Household Products
por: Binka, Mawuena, et al.
Publicado: (2015)

Hepatitis C Virus Coinfection in People With Human Immunodeficiency Virus in Iran: A Systematic Review and Meta-Analysis
por: Razavi-Amoli, Seyedeh-Kiana, et al.
Publicado: (2022)

Improving Diagnosis of Hepatitis C Virus Infection Using Hepatitis C Core Antigen Testing in a Resource-Poor Setting
por: Kannan, Ayswarya, et al.
Publicado: (2021)

Expanded HIV Clinic–Based Mental Health Care Services: Association With Viral Suppression
por: Aggarwal, Raina, et al.
Publicado: (2019)

Hepatitis C Screening in People With Human Immunodeficiency Virus: Lessons Learned From Syphilis Screening
por: Wurcel, Alysse G., et al.
Publicado: (2016)

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1
por: Linas, Benjamin P., et al.
Publicado: (2016)

Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya
por: Wahome, Elizabeth, et al.
Publicado: (2016)

Hepatitis C Virus Micro-elimination Among People With HIV in San Diego: Are We on Track?
por: Cheema, Jaskaran S, et al.
Publicado: (2023)

Occult Hepatitis B Virus Infection: An Old Entity With Novel Clinical Involvements
por: Malagnino, Vincenzo, et al.
Publicado: (2018)

Concomitant Treatment of Tuberculosis and Hepatitis C Virus in Coinfected Patients Using Serum Drug Concentration Monitoring
por: Ashkin, Alex, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fmnom2otldlh77o6s6lc8jslkv